医药前沿
醫藥前沿
의약전연
YIAYAO QIANYAN
2013年
1期
212
,共1页
小剂量%糖皮质激素%氨茶碱%老年哮喘%临床疗效
小劑量%糖皮質激素%氨茶堿%老年哮喘%臨床療效
소제량%당피질격소%안다감%노년효천%림상료효
smal dose%glucocorticoid%aminophyline elderly asthma%clinical%curative effect
目的研究并分析小剂量糖皮质激素联合氨茶碱对老年哮喘患者的临床治疗效果.方法选取我院门诊收治的280例老年哮喘患者为研究对象,所有研究对象均为2009年12月—2012年10月期间所收治的,将其进行随机分组,即对照组:140例患者运用单纯糖皮质激素的方式进行治疗;观察组:140例患者运用小剂量糖皮质激素联合氨茶碱进行治疗,对比对照组与观察组患者的临床治疗效果.结果观察组患者中,临床治疗显效89例,有效46例,无效5例,治疗的总有效率为96.43﹪,与对照组患者的82例、41例、17例,和87.86﹪相比,差异具有显著性(P<0.05).观察组患者的不良反应发生率为3.57﹪,相比于对照组患者的9.29﹪,差异具有显著性(P<0.05).结论运用小剂量糖皮质激素联合氨茶碱对老年哮喘患者进行治疗疗效确切,安全有效,值得推广.
目的研究併分析小劑量糖皮質激素聯閤氨茶堿對老年哮喘患者的臨床治療效果.方法選取我院門診收治的280例老年哮喘患者為研究對象,所有研究對象均為2009年12月—2012年10月期間所收治的,將其進行隨機分組,即對照組:140例患者運用單純糖皮質激素的方式進行治療;觀察組:140例患者運用小劑量糖皮質激素聯閤氨茶堿進行治療,對比對照組與觀察組患者的臨床治療效果.結果觀察組患者中,臨床治療顯效89例,有效46例,無效5例,治療的總有效率為96.43﹪,與對照組患者的82例、41例、17例,和87.86﹪相比,差異具有顯著性(P<0.05).觀察組患者的不良反應髮生率為3.57﹪,相比于對照組患者的9.29﹪,差異具有顯著性(P<0.05).結論運用小劑量糖皮質激素聯閤氨茶堿對老年哮喘患者進行治療療效確切,安全有效,值得推廣.
목적연구병분석소제량당피질격소연합안다감대노년효천환자적림상치료효과.방법선취아원문진수치적280례노년효천환자위연구대상,소유연구대상균위2009년12월—2012년10월기간소수치적,장기진행수궤분조,즉대조조:140례환자운용단순당피질격소적방식진행치료;관찰조:140례환자운용소제량당피질격소연합안다감진행치료,대비대조조여관찰조환자적림상치료효과.결과관찰조환자중,림상치료현효89례,유효46례,무효5례,치료적총유효솔위96.43﹪,여대조조환자적82례、41례、17례,화87.86﹪상비,차이구유현저성(P<0.05).관찰조환자적불량반응발생솔위3.57﹪,상비우대조조환자적9.29﹪,차이구유현저성(P<0.05).결론운용소제량당피질격소연합안다감대노년효천환자진행치료료효학절,안전유효,치득추엄.
objective: to study and the analysis of smal dose glucocorticoid joint aminophyline in elderly patients with asthma clinical therapeutic effect. Methods: the clinic were our 280 elderly cases of asthma patients as the research object, al the research objects are in December 2009-2012 during the October were randomized, wil the, i.e., the control group:140 patients using the simple way of glucocorticoid treatment; The observation group: 140 patients use smal dose glucocorticoid joint aminophyline treatment, compared to control group and observation group of patients with clinical therapeutic effect. Results: the observation group of patients, the clinical treatment of 89 cases were markedly effective, effective 46 cases effectiveness and 5 cases, treatment of the total effective rate was 96.43﹪, and in the patients in 82 cases, 41 cases, 17 cases, and 87.86﹪, compared with significant difference (P < 0.05). The observation group of patients with adverse reaction rate of 3.57﹪, compared to 9.29﹪ of the patients in control group, with significant difference (P < 0.05). Conclusion: using smal dose glucocorticoid joint aminophyline in elderly patients with asthma treatment effects were positive, safe and effective, and is worth popularizing.